Marc Dall'Era
University of California, Davis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Dall'Era as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06178354 · Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate CancerUniversity of California, Davis · recruiting · Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 · principal investigator
- Ph2NCT04030559 · Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsUniversity of California, Davis · terminated · ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation · principal investigator
- Ph1NCT02339168 · Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerUniversity of California, Davis · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Integrated Cancer Biology ProgramP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Wolf-Dietrich Heyer · fiscal years 2004 to 2026
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- 326 citationsRCR 8.3
- 240 citationsRCR 5.2
- Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.Arthritis Rheumatol · 2021167 citationsRCR 10.5
- 113 citationsRCR 4.2
- Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.Arthritis Rheumatol · 201582 citationsRCR 3.3
- Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer.Sci Rep · 202172 citationsRCR 4.2
- Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.Arthritis Care Res (Hoboken) · 201164 citationsRCR 1.9
- A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.Cancer · 201649 citationsRCR 1.4
- Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.PLoS Med · 201937 citationsRCR 2.7
- Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial.Lancet Rheumatol · 202427 citationsRCR 6.0